College of Pharmaceutical Sciences, Southwest University, Chongqing, People's Republic of China.
Int J Nanomedicine. 2013;8:1285-92. doi: 10.2147/IJN.S41695. Epub 2013 Mar 24.
The purpose of this study was to investigate flexible nanoliposomes for mediating topical delivery of daptomycin, and to document permeation rates and bacteriostatic activity towards skin infections. Response surface methodology was used to optimize the daptomycin-loaded flexible nanoliposomes (DAP-FL), and the amount of drug loaded into the particles was evaluated as the investigation index. The optimal lipid ratio was lecithin to sodium cholate 17:1 (w/w) and the lipid to drug ratio was 14:1 (w/w). The hydration temperature was set at 37°C and the duration of treatment with ultrasound was 20 minutes. The DAP-FL obtained had a small mean particle size (55.4 nm) with a narrow size distribution (polydispersity index 0.15). The mean entrapment efficiency was 87.85% ± 2.15% and the mean percent drug loading was 5.61% ± 0.14%. Using skin mounted between the donor and receptor compartments of a modified Franz diffusion cell, the percentage and quantity of cumulative daptomycin permeation from DAP-FL within 12 hours were measured at 96.28% ± 0.70% and (132.23 ± 17.73) μg/cm(2) *5 = 661.15 ± 88.65 μg/cm(2), directly, showing rapid and efficient antibacterial activity against Staphylococcus aureus. Following local administration of DAP-FL, daptomycin was detected in multilayer tissues within the skin and underlying structures in the dorsal skin of the mouse. Effective therapeutic concentrations were maintained for several hours, and significantly inhibited bacterial growth and injury-induced biofilms. These results demonstrate that the DAP-FL can enhance the ability of daptomycin to permeate the skin efficiently, where it has a powerful antibacterial action and activity against biofilms. This novel formulation of daptomycin has potential as a new approach in the clinical application of daptomycin.
本研究旨在探索柔性纳米脂质体介导达托霉素经皮给药的方法,并记录其对皮肤感染的渗透速率和抑菌活性。采用响应面法优化载药柔性纳米脂质体(DAP-FL),以载药量为考察指标。最优的脂质比为卵磷脂与胆酸钠 17:1(w/w),脂质与药物比为 14:1(w/w)。水化温度设定为 37°C,超声处理时间为 20 分钟。所得 DAP-FL 的平均粒径较小(55.4nm),粒径分布较窄(多分散指数为 0.15)。平均包封率为 87.85%±2.15%,平均载药量为 5.61%±0.14%。采用改良 Franz 扩散池,将皮肤夹在供体和受体室之间,在 12 小时内,DAP-FL 中达托霉素的累积渗透百分比和累积渗透量分别为 96.28%±0.70%和(132.23±17.73)μg/cm²*5=661.15±88.65μg/cm²,直接表明其对金黄色葡萄球菌具有快速、高效的抑菌活性。DAP-FL 局部给药后,在小鼠背部皮肤的多层组织和下方结构中检测到达托霉素。有效治疗浓度可维持数小时,并显著抑制细菌生长和损伤诱导的生物膜。这些结果表明,DAP-FL 可增强达托霉素高效穿透皮肤的能力,具有强大的抗菌作用和抗生物膜活性。这种新型达托霉素制剂具有作为达托霉素临床应用新方法的潜力。